Search

Parikh, A. R., I. Leshchiner, L. Elagina, L. Goyal, C. Levovitz, G. Siravegna, D. Livitz, et al. 2019. “Author Correction: Liquid versus Tissue Biopsy for Detecting Acquired Resistance and Tumor Heterogeneity in Gastrointestinal Cancers”. Nat Med 25: 1949.

Parsons, H. A., J. Rhoades, S. C. Reed, G. Gydush, P. Ram, P. Exman, K. Xiong, et al. 2020. “Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer”. Clin Cancer Res 26: 2556-64.

Penney, K. L., J. A. Sinnott, K. Fall, Y. Pawitan, Y. Hoshida, P. Kraft, J. R. Stark, et al. 2011. “MRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer”. J Clin Oncol 29: 2391-6.

Perry, J. A., A. Kiezun, P. Tonzi, E. M. Van Allen, S. L. Carter, S. C. Baca, G. S. Cowley, et al. 2014. “Complementary Genomic Approaches Highlight the PI3K/MTOR Pathway As a Common Vulnerability in Osteosarcoma”. Proc Natl Acad Sci U S A 111: E5564-73.

Savage, K. J., S. Monti, J. L. Kutok, G. Cattoretti, D. Neuberg, L. Leval, P. Kurtin, et al. 2003. “The Molecular Signature of Mediastinal Large B-Cell Lymphoma Differs from That of Other Diffuse Large B-Cell Lymphomas and Shares Features With Classical Hodgkin Lymphoma”. Blood 102: 3871-9.

Sboner, A., F. Demichelis, S. Calza, Y. Pawitan, S. R. Setlur, Y. Hoshida, S. Perner, et al. 2010. “Molecular Sampling of Prostate Cancer: A Dilemma for Predicting Disease Progression”. BMC Med Genomics 3: 8.

Setlur, S. R., K. D. Mertz, Y. Hoshida, F. Demichelis, M. Lupien, S. Perner, A. Sboner, et al. 2008. “Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer”. J Natl Cancer Inst 100: 815-25.

Solit, D. B., L. A. Garraway, C. A. Pratilas, A. Sawai, G. Getz, A. Basso, Q. Ye, et al. 2006. “BRAF Mutation Predicts Sensitivity to MEK Inhibition”. Nature 439: 358-62.

Stathias, V., A. M. Jermakowicz, M. E. Maloof, M. Forlin, W. Walters, R. K. Suter, M. A. Durante, et al. 2018. “Drug and Disease Signature Integration Identifies Synergistic Combinations in Glioblastoma”. Nat Commun 9: 5315.

Staunton, J. E., D. K. Slonim, H. A. Coller, P. Tamayo, M. J. Angelo, J. Park, U. Scherf, et al. 2001. “Chemosensitivity Prediction by Transcriptional Profiling”. Proc Natl Acad Sci U S A 98: 10787-92.